会议专题

Intramuscular injection of exogenous leptin induces adiposity,glucose intolerance and fatty liver by repressing the JAK2-STAT3/PI3K pathway in a rat model

  Obesity,diabetes and fatty liver disease are extremely common in leptin-resistant patients.Dysfunction of leptin or its receptor is associated with obesity.The present study aimed to assess the effects of intramuscular injection of exogenous leptin or its receptor on fat deposition and leptin-insulin feedback regulation.Forty-five 40-day old female Sprague Dawley(SD)rats were injected thrice with leptin or its receptor intramuscularly.Adiposity and fat deposition were assessed by assessing the Lee”s index,body weight,food intake,and total cholesterol,high density lipoprotein,low density lipoprotein,and triglyceride levels,as well as histological properties(liver and adipose tissue).Serum glucose,leptin,and insulin amounts were evaluated,and glucose tolerance assessed to monitor glucose metabolism in SD rats; pancreas specimens were analyzed immunohistochemically.Hypothalamic phosphorylated Janus kinase 2(p-JAK2),phosphorylated signal transducer and activator of transcription 3(p-STAT3),and phosphatidylinositol-3-kinase(PI3K)signaling,and hepatic sterol regulatory element binding protein-1(SREBP-1)were qualified by Western blotting.Leptin receptor immunogen reduced fat deposition,increased appetite,and lowered serum leptin levels,enhancing STAT3 signaling in hypothalamus and down-regulating hepatic SREBP-1.In contrast,SD rats administered leptin immunogen displayed significantly increased body weight and fat deposition,with up-regulated SREBP-1,indicating adiposity occurrence.SD rats administered leptin immunogen also showed glucose intolerance,b-cell reduction in the pancreas,and deregulation of JAK2-STAT3/PI3K signaling,indicating that Lep rats were at risk of diabetes.In conclusion,intramuscular injection of exogenous leptin or its receptor,a novel rat model approach,can be used in obesity pathogenesis and therapeutic studies.

Leptin Obesity Glucose intolerance Fatty liver JAK2-STAT3 PI3K

Lihong Wu Guoxiong Chen Wen Liu Xuechao Yang Jie Gao Liwen Huang Hongbing Guan Zhengmao Li Zhichao Zheng Meiling Li Weiwang Gu Linhu Ge

Key Laboratory of Oral Medicine,Guangzhou Institure of Oral Disease,Stomatology Hospital of Guangzho First Department of Orthopedics,The Affiliated Nanhai Hospital of Southern Medical University,Foshan Department of Laboratory Animal Center,Southern Medical University,Guangzhou 510515,China Key Laboratory of Oral Medicine,Guangzhou Institure of Oral Disease,Stomatology Hospital of Guangzho Department of Laboratory Animal Center,Southern Medical University,Guangzhou 510515,China;Department

国内会议

第十三届中国实验动物科学年会

成都

英文

1-9

2017-09-26(万方平台首次上网日期,不代表论文的发表时间)